Why do you still feel bad after detox is over?

Post-acute withdrawal syndrome is the continuation of withdrawal after acute detox resolves.

It is not a separate illness. It is the same neurological process running on a longer clock, because the brain's regulatory systems take considerably longer to recalibrate than the body takes to clear a substance. Clinicians also call it protracted withdrawal.

Acute withdrawal is the phase most people know: sweating, shaking, nausea and physical distress in the first days after stopping. What follows is milder in intensity and far longer in duration. The distinction matters because so many people believe they should feel normal once medical detox is finished, and read the persistence of symptoms as something going wrong rather than something going right. Knowing which phase you are in changes how you interpret a bad week.

This phase happens because chronic substance use reorganises the brain's core regulatory systems at a structural level. Dopamine receptor density is suppressed by sustained stimulant use and takes several weeks to recover. The GABA and glutamate balance that alcohol and benzodiazepines unsettle takes a similar period to restabilise. The opioid receptor system, once sensitised by prolonged exposure, needs weeks to normalise its response to ordinary reward.

The result is a brain that is technically substance-free but not yet functionally recovered. The reward system, which governs motivation, pleasure and emotional regulation, is running below baseline. The withdrawal monitoring protocols at Jintara track these changes across weeks rather than days, so the pattern is visible to the team before it is obvious to you. NIDA's account of how drugs affect the brain's reward circuit sets out the same mechanism in detail. That is why fatigue, flat mood and the inability to enjoy ordinary things are so characteristic of this phase.

Darren Lockie, Jintara's founder, describes why the excursion and activity components exist at all: "allowing your dopamine receptors or your pleasure centres to recover, so just starting to allow your brain to recover." Structured activity during this window is a clinical tool, not enrichment.

The core symptom cluster across every substance is mood instability, sleep disruption, cognitive slowing and fatigue. Beyond that core, each substance produces its own secondary pattern.

With alcohol, mood swings are pronounced, moving between sadness, irritability and anxiety inside the same day, and sleep stays broken even when anxiety is controlled. The week-by-week map of physical alcohol withdrawal symptoms shows how the acute phase hands over to this one. With benzodiazepines, rebound anxiety is the dominant symptom and is frequently worse than the anxiety the person was originally prescribed benzodiazepines to manage.

With opioids, anhedonia is the signature symptom: a reward system accustomed to opioid intensity finds ordinary life flat. SAMHSA's detoxification protocol covers the acute stage that precedes all of this. With stimulants, depression is often severe in the early weeks and carries real clinical risk. With cannabis, insomnia and irritability dominate and usually settle inside two to six weeks.

The timeline overlaps the stretch of early recovery when many people return to substance use. Acute withdrawal produces a strong aversion to using, because the person is physically unwell and the substance feels like the cause. The weeks that follow often bring a short stretch of cautious optimism. Then, somewhere around weeks four to eight, a confusing and demoralising question arrives: why do I still feel this bad?

It is at that point, when the acute phase is clearly behind them but relief has not arrived, that many people return to substance use. Not because they have given up, but because they read the persistence of symptoms as evidence that something is permanently wrong with them. NIDA is clear that relapse is common and does not mean treatment has failed, which is the frame worth holding here. Nobody warned them there was a second half.

Understanding the shape of it is itself protective. The relapse prevention work at Jintara begins well before discharge for exactly this reason, and it is built around the calendar rather than around willpower. A person who knows in advance that weeks four to eight are clinically the hardest stretch is in a far better position to hold on through them than someone who meets that stretch without warning. That is most of what this page is for.

Managing this phase has two components: supporting the physiological recovery, and addressing the thoughts that arise during it. The second is routinely underestimated. Thoughts like "I will never feel normal again", "this isn't working" and "a small amount would fix how I feel" are not random. They are a dysregulated brain reaching for relief along the pathways that chronic use built. Naming them as a symptom takes most of their power away.

Individual therapy sessions in this window focus on separating symptom-generated thinking from realistic appraisal. The aftercare planning built during the final week carries those same supports past the point of discharge, which matters because the hardest weeks often fall after a person goes home. Denise O'Leary, Clinical Director, puts the underlying mechanism plainly: "When you take away substances that you've been using to manage your emotions, the emotions are going to come back online, and sometimes they will do that with a vengeance."

Activity scheduling, sleep routines and the morning check-in groups do the same normalising work from a different direction. Hearing from somebody three weeks further along that the mood swings settled carries a weight that reassurance from a clinician cannot match.

There is no separate program layer and no optional add-on for this. It sits inside the standard clinical week from week two onward, because the clinical team states the reality directly. Denise O'Leary: "You're not done withdrawing until about three weeks after you get to zero." Designing around that means clients do not meet the difficult middle unaccompanied.

Medical monitoring extends past the acute phase. Nursing assessments continue across weeks two to four, tracking mood stability, sleep quality, appetite and cognitive function. Therapy in this window shifts from detox support toward psychoeducation about the recovery process, identifying the thought patterns above, and starting the trigger mapping that becomes the foundation of the discharge plan.

For people with a co-occurring mental health condition there is an extra layer of difficulty, because low mood driven by withdrawal and a depressive episode can look identical from the outside, as can withdrawal anxiety and a pre-existing anxiety disorder. The dual diagnosis approach at Jintara separates the two rather than treating every post-detox emotional symptom as equivalent, and SAMHSA's guidance on treating co-occurring disorders sets out why that distinction changes the treatment. Clients are told which is which.